NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated July 13, 2026

Aripiprazole

Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026

Prescription second-generation (atypical) antipsychotic approved for schizophrenia, bipolar I disorder, adjunctive treatment for major depressive disorder, irritability associated with autistic disorder, and Tourette's disorder. Unique among antipsychotics as a dopamine D2 partial agonist, providing a more balanced dopaminergic modulation with a lower risk of metabolic side effects and extrapyramidal symptoms. Dosage must be determined by your prescribing physician.

Evidence tier
Strong
Indexed sources
11 2009–2024
Interactions
0
Category
Prescription
Read the sources → Compare profiles
Publication status

Exploratory record, not a reviewed medical publication.

See the editorial and medical-review policies for the publication gate.

This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.

In short

What the research says.

A quick, data-only summary. The full evidence, dosing, and sources are below.

Prescription second-generation (atypical) antipsychotic approved for schizophrenia, bipolar I disorder, adjunctive treatment for major depressive disorder, irritability associated with autistic disorder, and Tourette's disorder. NutriStack rates the supporting evidence as strong. Common adult dosing is 2–30 mg daily depending on indication (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 11 sources.

What it's good for
  • Psychotic symptom reduction
  • Bipolar mood stabilization
  • Adjunctive depression treatment7,10
  • Lower metabolic side effect burden3
  • Reduced extrapyramidal symptoms
What to watch for
  • Akathisia (restlessness)
  • Insomnia
  • Headache
  • Known hypersensitivity to aripiprazole1,2
  • Concurrent strong CYP2D6 or CYP3A4 inhibitors (dose adjustment required)

The bottom line

Evidence rating strong. Most-documented uses: psychotic symptom reduction, bipolar mood stabilization, adjunctive depression treatment. 11 sources indexed (2009–2024), with 0 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors. As a D2 partial agonist, it stabilizes dopamine activity, reducing excessive dopamine transmission in mesolimbic pathways (antipsychotic effect) while preserving dopamine function in mesocortical and nigrostriatal pathways (fewer cognitive and motor side effects).

Class
Atypical Antipsychotic
Absorption
Fat-soluble; take with food
Dosing

Dosing & protocol.

Common range
2–30 mg daily depending on indication (as prescribed by your physician)
Recommended form
Tablet, orally disintegrating tablet, oral solution, or long-acting injectable

Can be taken with or without food. Long-acting injectable formulations (Abilify Maintena, Aristada) available for monthly or every-2-month dosing.

Safety

Full safety detail.

Side effects

  • Akathisia (restlessness)
  • Insomnia
  • Headache
  • Nausea
  • Dizziness
  • Weight gain (less than other atypicals)
  • Constipation

Contraindications

  • Known hypersensitivity to aripiprazole1,2
  • Concurrent strong CYP2D6 or CYP3A4 inhibitors (dose adjustment required)
  • Concurrent strong CYP3A4 inducers (dose adjustment required)
Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

7

Reviews & position papers

1

Reference material

3
FAQ

Common questions.

Quick answers about Aripiprazole, drawn from the data on this page.

What is Aripiprazole?

Prescription second-generation (atypical) antipsychotic approved for schizophrenia, bipolar I disorder, adjunctive treatment for major depressive disorder, irritability associated with autistic disorder, and Tourette's disorder. Unique among antipsychotics as a dopamine D2 partial agonist, providing a more balanced dopaminergic modulation with a lower risk of metabolic side effects and extrapyramidal symptoms. Dosage must be determined by your prescribing physician.

What is Aripiprazole used for?

Commonly cited benefits of Aripiprazole include: Psychotic symptom reduction; Bipolar mood stabilization; Adjunctive depression treatment; Lower metabolic side effect burden; Reduced extrapyramidal symptoms. NutriStack rates the overall evidence as strong.

What is a typical dose of Aripiprazole?

A typical adult dose of Aripiprazole is 2–30 mg daily depending on indication (as prescribed by your physician). The commonly recommended form is Tablet, orally disintegrating tablet, oral solution, or long-acting injectable. These are general ranges, not personalized advice; confirm the right dose with a clinician.

What are the side effects of Aripiprazole?

Reported side effects include akathisia (restlessness), insomnia, headache, nausea, dizziness, weight gain (less than other atypicals). This is educational information; check with a healthcare professional before use.

How strong is the evidence for Aripiprazole?

NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.

Use this with your stack

Aripiprazole in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

Download on the App Store → Read the methodology

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.